Tag: Compass Pathways - Psychedelic Alpha

Access exclusive insights, data and interviews with Pα+: learn more and subscribe today.

Read more about the article COMPASS Pathways appoints Daphne Karydas to its Board of Directors

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

Post published:September 19, 2023
Post category:Press Release

Read more about the article COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

COMPASS Pathways announces publication of first study evaluating potential of AI model to predict outcomes of COMP360 psilocybin treatment in treatment-resistant depression

Post published:September 6, 2023
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming September investor conferences

COMPASS Pathways to participate in upcoming September investor conferences

Post published:August 29, 2023
Post category:Press Release

Read more about the article COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthcare Investors

Post published:August 16, 2023
Post category:Press Release

Read more about the article COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

COMPASS Pathways Announces Second Quarter 2023 Financial Results and Business Highlights

Post published:August 3, 2023
Post category:Press Release

Read more about the article COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

COMPASS Pathways plc to announce second quarter 2023 financial results on August 3, 2023

Post published:July 31, 2023
Post category:Press Release

Read more about the article First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

First clinical study results of psilocybin treatment in anorexia nervosa published in Nature Medicine

Post published:July 25, 2023
Post category:Press Release

Read more about the article COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology

COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of COMP360 psilocybin alongside antidepressants in Nature journal, Neuropsychopharmacology

Post published:July 17, 2023
Post category:Press Release

Read more about the article Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Opinion paper calls for clarity on the definition of “psychedelic-assisted therapy” using psilocybin

Post published:July 13, 2023
Post category:Press Release

Read more about the article American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies

American Medical Association Releases Language of First New Current Procedural Terminology Code for Psychedelic Therapies

Post published:July 6, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.